BBC Webinar – Drug Trends and More – A Discussion on Improving Value on Drug Spend with Industry Leaders

$50.00

Thursday, June 17, 2021
8:30AM – 11:15AM (ET)

Join us on June 17th as we close off our 2020-21 season with an engaging presentation and discussion format with industry experts on drug trends, analytics, plan design, and patient and disease management.

Group Registration – if you would like to register multiple attendees, please select the desired ticket quantity below and you will be asked to provide registration details upon checkout.

Category:

Chair and Moderator
Denise Balch, President, Connex Health

Drug Trends
Jeff Boutilier, General Manager, Pharmacy and Chief Clinical Officers with Express Scripts Canada

Jeff will explore the 2021 Express Scripts Prescription Drug Trends report, focussing on some specific disease trends, the impact of COVID-19, Law 41, and new innovations in detecting nonadherence trends.

Expert Panel

After a brief one-on-one with each panel member, Denise Balch will moderate an interactive discussion exploring the impact of compliance and adherence, step therapy, plan maximums and pooling limits, as well as other industry trends to manage drug spend without compromising quality care.

Jeff Boutilier, General Manager, Pharmacy and Chief Clinical Officers, Express Scripts Canada

Mike McClenahan, Managing Partner, Benefits By Design (now part of People Corporation)

Paul Henricks, Associate Director, Data Innovation and Insights, PDCI Market Access

Mike Cavanagh, Pharmacist/Owner, Pharmasave Kawartha Lakes Pharmacy and Co-Chair, Pharmacy and Health Insurance Steering Coalition (PHISC)

CE Credits

If you are located anywhere in Canada except Alberta, you will receive 2.0 CE Credits on completion of a brief online post-session quiz.

Thank you to our Benefits Breakfast Club (BBC) sponsors for their support during COVID-19. Find out who our sponsors are here. Thank you to sponsors who have already renewed for our 2021-22 season: Abbvie, AMGEN, Astra Zeneca, The Canadian Association of Optometrists, GlaxoSmithKline, Janssen Inc., Novartis, Novo Nordisk and Roche; emerging sponsor Innovative Medicines Canada and regional sponsor Abbott.